Zydus Lifesciences’ anaemia drug Desidustat receives NMPA approval in China, targeting non-dialysis CKD patients.

Ghaziabad: A 26-year-old man from Meerut received a second chance at life after his mother donated a kidney to him despite ...

The biological passport doesn’t catch cheaters red-handed but can still end careers. Here's how the controversial tool works ...

Seth Clevenger won yet another Division-III national championship in track and field on Saturday, less than six months after ...

The Senegal national football side has just been stripped of the Africa Cup of Nations.

On World Kidney Day, let's understand how kidney disease often progresses silently, the warning signs to watch for, and why ...

Zydus Lifesciences Limited announced that its innovative drug Desidustat tablets, licensed to the subsidiary of China Medical ...

Zydus Lifesciences said its Desidustat tablets, licensed to a subsidiary of China Medical System Holdings (CMS), have been approved in China for treating renal anaemia by the National Medical Products ...

The 'two-strikes-and-out' doping rule on teams can seem blunt and unfair, but cycling’s history means the sport still can’t ...

Explore the world’s highest sports venues, from Peru’s football stadium to Bhutan’s pool, set at breathtaking, ...

China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that on 13 March 2026, new drug for renal anaemia Desidustat Tablets (the “Product”) has been approved for ...

Analysis - Last October, my daughter Elizabeth and I stood at Londorossi gate (elevation 2,250 metres), the western entrance to Mount Kilimanjaro National Park in Tanzania, ready to begin the nine-day ...